Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Infectious Disease
•
General Infectious Disease
What is your approach to managing antimicrobial therapy for intra-abdominal infections to avoid unnecessary double anaerobic coverage, in light of associated risks and guidelines?
Related Questions
How do you approach the use of Paxlovid in patients with COVID-19 and CKD Stage 4?
Under what circumstance would you order dalbavancin instead of vancomycin or daptomycin for MRSA endocarditis?
Would you recommend using a rectal swab for C difficile testing in an inpatient with diarrhea if nurses have been unable to collect a stool sample for 24 hours due to the patient not cooperating with collection?
What duration of antibiotic therapy do you use for a loculated parapneumonic effusion that does not meet criteria for empyema?
Do you routinely prescribe linezolid to patients who are concomitantly on methadone?
What role could emerging technologies, such as antimicrobial coatings or biofilm-disrupting agents, play in reducing the incidence of CIED infections?
Do you routinely use oral vancomycin prophylaxis in patients with a history of CDI who are receiving antibiotics?
How would you manage and determine the duration of antibiotics for a patient with suspected chronic postoperative spinal implant infection, status post lumbar fusion, now presenting with loosened hardware on imaging, normal inflammatory markers, and no systemic infection symptoms?
In a patient with CIED lead infection and bacteremia who had blood cultures cleared before CIED extraction, do we still need 72 hrs of documented negative blood cultures obtained post extraction to consider reimplantation and can we do same-time extraction and reimplantation?
Do you routinely recommend an immunodeficiency work up in patients with ARDS due to influenza infection who develop invasive pulmonary aspergillosis?
